The neuronal ceroid lipofuscinosis type 2 – associated variants: An analysis of alterations in the TPP1 gene and genotype–phenotype correlation in Ukraine
Authors:
- Nataliia OlkhovychNONataliia Olkhovych
- Nataliia PichkurNPNataliia Pichkur
- Nataliia MytsykNMNataliia Mytsyk
- Rodolfo ToninRTRodolfo Tonin
- Svitlana KormozSKSvitlana Kormoz
- Iryna HregulIHIryna Hregul
- Nataliia SamonenkoNSNataliia Samonenko
- Tetiana ShklyarskayaTSTetiana Shklyarskaya
- Volodymyr OlkhovychVOVolodymyr Olkhovych
- Olexandr BuryakOBOlexandr Buryak
- Amelia MorroneAMAmelia Morrone
- Nataliia GorovenkoNGNataliia Gorovenko
Open Access
- 14 May 2024
- journal article
- research article
- Published by Wiley in JIMD Reports
- Vol. 65 (4) , 272-279
Abstract
The neuronal ceroid lipofuscinosis type 2 (CLN2) is a heterogeneous group of neurodegenerative lysosomal storage disorders caused by autosomal recessive inheritance of two pathogenic variants in trans in the TPP1 gene. Classical late‐infantile CLN2 disease has a very well‐defined natural history. However, a small number of patients with TPP1 enzyme deficiency present a later onset or protracted disease course within this group there are phenotypic variants. Our work aimed to identify pathological variants in the TPP1 gene that conditioned the development of CLN2 disease in Ukrainian patients, to compare these variants with those found in patients from other European and non‐European regions, and to make genotype–phenotype associations for this disease. The phenotypes and genotypes of the 48 CLN2‐affected individuals belonging to 43 families were profiled through clinical data collection, enzyme analysis, and genotyping. In most patients, genotype and phenotype correlation are in keeping with the data of previous studies. The clinical signs of the disease in patients with new, previously undescribed variants, allowed us to augment existing data about genotype–phenotype correlations for CLN2 disease. The combination of genotype and clinical form of the disease demonstrated that predicting the type and clinical course of the disease based on genotype is very complicated. The data we obtained supplements existing information on genotype–phenotypic correlations in this rare disease, which, in turn, lays the foundation for a personalized approach to the management of this disease.Keywords
This publication has 14 references indexed in Scilit:
- Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 diseaseHuman Mutation, 2019
- Study of Intraventricular Cerliponase Alfa for CLN2 DiseaseNew England Journal of Medicine, 2018
- Management Strategies for CLN2 DiseasePediatric Neurology, 2017
- Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosisMolecular Genetics and Metabolism, 2016
- Natural History of CLN2 Disease: Quantitative Assessment of Disease Characteristics and Rate of ProgressionNeuropediatrics, 2016
- HGVS Recommendations for the Description of Sequence Variants: 2016 UpdateHuman Mutation, 2016
- Neuronal ceroid lipofuscinosis type CLN2: A new rationale for the construction of phenotypic subgroups based on a survey of 25 cases in South AmericaGene, 2013
- Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinosesHuman Mutation, 2011
- Neuronal ceroid lipofuscinosesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- Mutational Analysis of the Defective Protease in Classic Late-Infantile Neuronal Ceroid Lipofuscinosis, a Neurodegenerative Lysosomal Storage DisorderThe American Journal of Human Genetics, 1999